<DOC>
	<DOCNO>NCT01596439</DOCNO>
	<brief_summary>The primary objective prospective pilot study examine variation cognitive function various time-points stage I-III breast cancer patient undergone undergoing adjuvant systemic therapy ( chemotherapy and/or anti-hormonal therapy ) compare group healthy control evaluate difference . All randomized patient respective control would require complete computerized neuropsychological assessment CANTAB certain time-points.These patient control would also give day CANTAB testing , set questionnaire evaluate subjective factor anxiety , depression , fatigue menopausal symptom may also effect cognition . Subjective assessment cognitive function rely self-reporting study participant use validate questionnaire.The potential risk subject minimal , study without intervention regard medical management patient . By participate study , subject help aim determine cognitive impairment post-therapy , , prevalent phenomenon , arise change time . This consequentially play important role regard patient knowledge . Furthermore , chemotherapy show associated cognitive impairment , study carry determine exact pathophysiology behind phenomenon . This allow sensitive timely detection cognitive dysfunction patient receive chemotherapy and/or anti-hormonal therapy , subsequently open avenue research prevent alleviate phenomenon . This crucial improving patient ' quality life , social occupational performance . The investigator hypothesis systemic adjuvant therapy form chemotherapy and/or anti-hormonal therapy give primary breast cancer patient cause cognitive impairment .</brief_summary>
	<brief_title>A Prospective Study Evaluate Effect Systemic Adjuvant Therapy Cognitive Function Breast Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>1 . Histologically confirm stage IIII breast carcinoma 2 . &lt; 65 year old 3 . Female 1 . Previous exposure chemotherapy/antihormonal therapy malignancy 2 . Previous neoadjuvant therapy breast cancer 3 . Concomitant second primary insitu invasive carcinoma previous history carcinoma/carcinomainsitu 4 . Known disease injury central nervous system ( include neurodegenerative disease , epilepsy ) , severe visual auditory disorder 5 . Motor weakness due cause make use touchscreen computer difficult 6 . Known background depression , anxiety disorder neurobehavioural condition 7 . Ongoing use tranquilisers antidepressant 8 . Previous neuropsychological test 9 . Current previous history alcohol drug dependent</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Healthy woman</keyword>
	<keyword>consist friend relative patient</keyword>
</DOC>